Stock-Based Compensation (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Apr. 30, 2026 |
Jun. 30, 2026 |
|
| 2023 Plan [Member] | ||
| Schedule of Stock-Based Compensation Expense [Line Items] | ||
| Available for grant (in Shares) | 2,791,063 | |
| RSU [Member] | ||
| Schedule of Stock-Based Compensation Expense [Line Items] | ||
| Unrecognized compensation expense | $ 500 | |
| Recognized over a weighted-average period | 9 months | |
| Granted shares of restricted stock | 600,000 | |
| Vested shares | 309,700 | |
| Remaining vested shares | 300,000 | |
| Grant date fair value | $ 1,100,000 | |
| RSU [Member] | Chief Executive Officer [Member] | ||
| Schedule of Stock-Based Compensation Expense [Line Items] | ||
| Vested shares | 300,000 | |
| Stock Options [Member] | ||
| Schedule of Stock-Based Compensation Expense [Line Items] | ||
| Unrecognized compensation expense | $ 800,000 | |
| Recognized over a weighted-average period | 1 year 2 months 12 days |
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans remaining (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). No definition available.
|
| X | ||||||||||
- Definition Fair value portion of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|